In Europe and the US there are close to 20 million people that live with cancer today, a figure that is increasing. 6.2 million people worldwide died of cancer in 1998. The American Cancer Society estimates that approximately 1.2 million new cancer cases were diagnosed in the year 2000 in the US. Overall annual costs associated with cancer currently amount to $107 billion in the United States alone. The worldwide anti-cancer market was valued at more than $15 billion in 1998 and is projected to nearly double by 2003. Approximately 30% of all collaborative deals are signed in the field of cancer.
According to the American Cancer Society, after skin cancer, prostate cancer is the most common type of cancer found in American men and is the second leading cause of cancer deaths in men, exceeded only by lung cancer. In 2003, there will be an estimated 221 000 new cases of prostate cancer in the United States, and about 29 000 men will die of the disease.
This report will assist you in:
-Tracking cutting edge companies, therapies and new technologies -Rapid identification of partners & competitors -Laying down a comprehensive framework for further analysis of the field -Producing presentations surrounding the development of prostate cancer therapeutics -Identifying emerging prostate cancer products & key areas of pharmaceutical R&D
